TST
Thiosulfate sulfurtransferase
Also known as: RDS, THTR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16762
- Gene
- TST
- Ensembl
- ENSG00000128311
- Chromosome
- 22
- Canonical length
- 297 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This is one of two neighboring genes encoding similar proteins that each contain two rhodanese domains. The encoded protein is localized to the mitochondria and catalyzes the conversion of thiosulfate and cyanide to thiocyanate and sulfite. In addition, the protein interacts with 5S ribosomal RNA and facilitates its import into the mitochondria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q16762|TST
1 MVHQVLYRAL VSTKWLAESI RTGKLGPGLR VLDASWYSPG TREARKEYLE RHVPGASFFD
61 IEECRDTASP YEMMLPSEAG FAEYVGRLGI SNHTHVVVYD GEHLGSFYAP RVWWMFRVFG
121 HRTVSVLNGG FRNWLKEGHP VTSEPSRPEP AVFKATLDRS LLKTYEQVLE NLESKRFQLV
181 DSRSQGRFLG TEPEPDAVGL DSGHIRGAVN MPFMDFLTED GFEKGPEELR ALFQTKKVDL
241 SQPLIATCRK GVTACHVALA AYLCGKPDVA VYDGSWSEWF RRAPPESRVS QGKSEKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TST can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 556 nTPM
Expression across tissuesHPA
Tissue
- liver: 556 nTPM
- colon: 186 nTPM
- adrenal gland: 151 nTPM
- duodenum: 139 nTPM
- small intestine: 108 nTPM
- kidney: 100 nTPM
Single-cell type
- colonocytes: 527 nCPM
- hepatocytes: 437 nCPM
- esophageal apical cells: 405 nCPM
- enterocytes: 254 nCPM
- platelets: 227 nCPM
- enteric transient amplifying cells: 209 nCPM
Immune cell
- myeloid DC: 25 nTPM
- neutrophil: 22 nTPM
- classical monocyte: 18 nTPM
- basophil: 11 nTPM
- total PBMC: 8.1 nTPM
- eosinophil: 8 nTPM
Brain region
- basal ganglia: 44 nTPM
- white matter: 40 nTPM
- cerebellum: 40 nTPM
- thalamus: 36 nTPM
- spinal cord: 34 nTPM
- midbrain: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cyanate catabolic process
- epithelial cell differentiation
- rRNA import into mitochondrion
- sulfur amino acid catabolic process
- rRNA transport
Molecular functions
- 3-mercaptopyruvate sulfurtransferase activity
- 5S rRNA binding
- thiosulfate-cyanide sulfurtransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TST in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TST as an antibody target. Whether an autoantibody or antibody against TST could matter depends on whether native TST is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TST is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TST as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...